1979
DOI: 10.1016/s0140-6736(79)91146-2
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Pentagastrin-Stimulated and Nocturnal Gastric Secretion by Ranitidine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
30
0

Year Published

1981
1981
2017
2017

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 99 publications
(30 citation statements)
references
References 4 publications
0
30
0
Order By: Relevance
“…These results are in accord with the present in vitro studies and previous reports that metiamide and cimetidine possess a similar level of activity (Brimblecombe et al, 1975). Other studies have shown ranitidine to inhibit gastric acid secretion in the dog (Bradshaw et al, 1979;Daly, Humphray & Stables, 1980) and man (Peden, Saunders & Wormsley, 1979).…”
Section: In Vivo Antisecretory Experimentsmentioning
confidence: 89%
“…These results are in accord with the present in vitro studies and previous reports that metiamide and cimetidine possess a similar level of activity (Brimblecombe et al, 1975). Other studies have shown ranitidine to inhibit gastric acid secretion in the dog (Bradshaw et al, 1979;Daly, Humphray & Stables, 1980) and man (Peden, Saunders & Wormsley, 1979).…”
Section: In Vivo Antisecretory Experimentsmentioning
confidence: 89%
“…When administered in man, the dose of pyridostigmine is normally 4-5 times greater than neostigmine, due to differences in their potency. Experimental evidence suggests that the half-life of larger doses of pyridostigmine is prolonged (Baker et al, 1978) This drug is reported to be several times more potent than cimetidine on a molar basis (Peden, Saunders & Wormsley, 1979;Domschke, Lux, Domschke & Demling, 1979) and, hence, the theoretical possibility exists that this more potent drug may cause pancreatic damage.…”
Section: Kinetics Of Intravenous Pyridostigmine In Manmentioning
confidence: 99%
“…Peptic ulcer is a common disease worldwide, with an estimated 10% of the population effected. Research has shown that the infection of Helicobacter pylori is a key factor in the occurrence and reoccurrence of peptic ulcer [8,9] . Tiemonium Methylsulfate (Figure 2) is chemically described as 4-(3-hydroxy-3-phenyl-3-(2-thienyl) propyl)-4-methyl morpholinium methylsulfate (salt).…”
Section: Introductionmentioning
confidence: 99%